Tokyo Tape
Sign in
← Chiome Bioscience

Quarterly report · Q3

4583.TEDINET S100PLJL
Period2022-01-01 → 2022-09-30
Filed2022-11-14
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 34
MetricValuePeriodScopeSource row
Revenue¥434m2022-01-01 → 2022-09-30StandaloneNet sales
Revenue¥713m2021-01-01 → 2021-12-31StandaloneNet sales (5-year summary)
Revenue¥542m2021-01-01 → 2021-09-30StandaloneNet sales
Operating income−¥1.0bn2022-01-01 → 2022-09-30StandaloneOperating income
Operating income−¥851m2021-01-01 → 2021-09-30StandaloneOperating income
Ordinary income−¥1.0bn2022-01-01 → 2022-09-30StandaloneOrdinary income
Ordinary income−¥1.3bn2021-01-01 → 2021-12-31StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥843m2021-01-01 → 2021-09-30StandaloneOrdinary income
Profit before tax−¥1.0bn2022-01-01 → 2022-09-30StandaloneIncome before income taxes
Profit before tax−¥830m2021-01-01 → 2021-09-30StandaloneIncome before income taxes
Net income−¥1.0bn2022-01-01 → 2022-09-30StandaloneProfit loss
Net income−¥1.5bn2021-01-01 → 2021-12-31StandaloneNet income loss (5-year summary)
Net income−¥843m2021-01-01 → 2021-09-30StandaloneProfit loss
Total assets¥2.1bnat 2022-09-30StandaloneAssets
Total assets¥2.3bnat 2021-12-31StandaloneAssets
Total assets¥3.0bnat 2021-09-30StandaloneTotal assets (5-year summary)
Total liabilities¥431mat 2022-09-30StandaloneLiabilities
Total liabilities¥446mat 2021-12-31StandaloneLiabilities
Net assets / equity¥1.7bnat 2022-09-30StandaloneNet assets
Net assets / equity¥1.9bnat 2021-12-31StandaloneNet assets
Net assets / equity¥2.4bnat 2021-09-30StandaloneNet assets (5-year summary)
Cash and deposits¥1.6bnat 2022-09-30StandaloneCash and deposits
Cash and deposits¥1.8bnat 2021-12-31StandaloneCash and deposits
EPS (basic)¥-23.872022-01-01 → 2022-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-5.82022-07-01 → 2022-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-36.742021-01-01 → 2021-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-20.942021-01-01 → 2021-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-10.772021-07-01 → 2021-09-30dStandaloneBasic earnings loss per share (5-year summary)
Equity ratio78.4%at 2022-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio79.4%at 2021-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio81.6%at 2021-09-30StandaloneEquity to asset ratio (5-year summary)
Shares issued45,979,100at 2022-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued40,781,500at 2021-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued40,305,500at 2021-09-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-09-30−¥358m
jpcrp040300-q3r_E26096-000Drug Discovery And Developmentreportable segmentsegment profit2022-01-01 → 2022-09-30−¥916m
jpcrp040300-q3r_E26096-000Drug Discovery Supportreportable segmentrevenue2022-01-01 → 2022-09-30¥434m
jpcrp040300-q3r_E26096-000Drug Discovery Supportreportable segmentrevenue external2022-01-01 → 2022-09-30¥434m
jpcrp040300-q3r_E26096-000Drug Discovery Supportreportable segmentsegment profit2022-01-01 → 2022-09-30¥235m
Total Of Reportable Segments And Otherssegment totalrevenue2022-01-01 → 2022-09-30¥434m
Total Of Reportable Segments And Otherssegment totalrevenue external2022-01-01 → 2022-09-30¥434m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-01-01 → 2022-09-30−¥681m
Reconciling Itemsreconcilingsegment profit2021-01-01 → 2021-09-30−¥328m
jpcrp040300-q3r_E26096-000Drug Discovery And Developmentreportable segmentrevenue2021-01-01 → 2021-09-30¥103m
jpcrp040300-q3r_E26096-000Drug Discovery And Developmentreportable segmentrevenue external2021-01-01 → 2021-09-30¥103m
jpcrp040300-q3r_E26096-000Drug Discovery And Developmentreportable segmentsegment profit2021-01-01 → 2021-09-30−¥757m
jpcrp040300-q3r_E26096-000Drug Discovery Supportreportable segmentrevenue2021-01-01 → 2021-09-30¥439m
jpcrp040300-q3r_E26096-000Drug Discovery Supportreportable segmentrevenue external2021-01-01 → 2021-09-30¥439m
jpcrp040300-q3r_E26096-000Drug Discovery Supportreportable segmentsegment profit2021-01-01 → 2021-09-30¥235m
Total Of Reportable Segments And Otherssegment totalrevenue2021-01-01 → 2021-09-30¥542m
Total Of Reportable Segments And Otherssegment totalrevenue external2021-01-01 → 2021-09-30¥542m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-01-01 → 2021-09-30−¥523m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 325
ItemContextValueUnit
Number of voting rights issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember－
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsTreasurySharesEtcMember100
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember43047500
Number of voting rights issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember430475
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember10000
Number of shares issued shares voting rightsCurrentQuarterInstant43057600
Number of voting rights issued shares voting rightsCurrentQuarterInstant430475
Number of shares held in own name treasury shares etcCurrentQuarterInstant_Row1Member100
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row1Member－
Total number of shares held treasury shares etcCurrentQuarterInstant_Row1Member100
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row1Member0.000
Number of shares held in own name treasury shares etcCurrentQuarterInstant100
Number of shares held in others names treasury shares etcCurrentQuarterInstant－
Total number of shares held treasury shares etcCurrentQuarterInstant100
Shareholding ratio treasury shares etcCurrentQuarterInstant0.000
Cash and depositsPrior1YearInstant_NonConsolidatedMember1790988000JPY
Cash and depositsCurrentQuarterInstant_NonConsolidatedMember1592118000JPY
Accounts receivable tradePrior1YearInstant_NonConsolidatedMember25456000JPY
Accounts receivable tradeCurrentQuarterInstant_NonConsolidatedMember84751000JPY
InventoriesPrior1YearInstant_NonConsolidatedMember59049000JPY
InventoriesCurrentQuarterInstant_NonConsolidatedMember78174000JPY
Advance payments tradePrior1YearInstant_NonConsolidatedMember270440000JPY
Advance payments tradeCurrentQuarterInstant_NonConsolidatedMember106192000JPY
Consumption taxes receivablePrior1YearInstant_NonConsolidatedMember36050000JPY
Consumption taxes receivableCurrentQuarterInstant_NonConsolidatedMember29271000JPY
Other caPrior1YearInstant_NonConsolidatedMember34898000JPY
Other caCurrentQuarterInstant_NonConsolidatedMember65329000JPY
Current assetsPrior1YearInstant_NonConsolidatedMember2216883000JPY
Current assetsCurrentQuarterInstant_NonConsolidatedMember1955837000JPY
Machinery and equipmentPrior1YearInstant_NonConsolidatedMember291571000JPY
Machinery and equipmentCurrentQuarterInstant_NonConsolidatedMember257893000JPY
Accumulated depreciation machinery and equipmentPrior1YearInstant_NonConsolidatedMember-287372000JPY
Accumulated depreciation machinery and equipmentCurrentQuarterInstant_NonConsolidatedMember-255099000JPY
Machinery and equipment netPrior1YearInstant_NonConsolidatedMember4199000JPY
Machinery and equipment netCurrentQuarterInstant_NonConsolidatedMember2793000JPY
Tools furniture and fixturesPrior1YearInstant_NonConsolidatedMember95820000JPY
Tools furniture and fixturesCurrentQuarterInstant_NonConsolidatedMember97242000JPY
Accumulated depreciation tools furniture and fixturesPrior1YearInstant_NonConsolidatedMember-95820000JPY
Accumulated depreciation tools furniture and fixturesCurrentQuarterInstant_NonConsolidatedMember-97242000JPY
Tools furniture and fixtures netPrior1YearInstant_NonConsolidatedMember0JPY
Tools furniture and fixtures netCurrentQuarterInstant_NonConsolidatedMember0JPY
Property plant and equipmentPrior1YearInstant_NonConsolidatedMember4199000JPY
Property plant and equipmentCurrentQuarterInstant_NonConsolidatedMember2793000JPY
Long term prepaid expensesPrior1YearInstant_NonConsolidatedMember5544000JPY
Long term prepaid expensesCurrentQuarterInstant_NonConsolidatedMember10010000JPY
Lease and guarantee depositsPrior1YearInstant_NonConsolidatedMember112811000JPY
Lease and guarantee depositsCurrentQuarterInstant_NonConsolidatedMember112811000JPY
Other ioaPrior1YearInstant_NonConsolidatedMember0JPY
Other ioaCurrentQuarterInstant_NonConsolidatedMember0JPY
Investments and other assetsPrior1YearInstant_NonConsolidatedMember118355000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 10 of 10 passed
balance sheet identitynon_consolidated 2021-12-31pass
balance sheet identitynon_consolidated 2022-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2021-12-31pass
statement vs summary · net assetsnon_consolidated 2022-09-30pass
statement vs summary · revenuenon_consolidated 2021-01-01/2021-09-30pass
statement vs summary · revenuenon_consolidated 2022-01-01/2022-09-30pass
statement vs summary · total assetsnon_consolidated 2021-12-31pass
statement vs summary · total assetsnon_consolidated 2022-09-30pass